Blackstone’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
BBA
Blackstone's STOK Position: Q2 2026 in Review
Blackstone sold out of Stoke Therapeutics (STOK) in Q2 2026, closing a stake of 30,579 shares — an estimated $996K sold.
Blackstone first reported a position in STOK in Q2 2019 and held it in 2 quarters. The position peaked at $996K in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.
- Blackstone reported no remaining Stoke Therapeutics position as of Q2 2026 after selling out during the quarter.
- Blackstone sold 30,579 Stoke Therapeutics shares in Q2 2026, an estimated $996K.
- Blackstone first reported a position in Stoke Therapeutics in Q2 2019 and held it in 2 quarters.
- Blackstone's Stoke Therapeutics position peaked at $996K in Q1 2026.
- 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.